Lieff Cabraser partner David Rudolph will speak at the American Bar Association’s 25th Annual National Institute on Class Actions on Wednesday, April 13th, 2022 at 10:00 am CT at The Driskill Hotel in Austin, Texas. David will be featured on the panel “Don’t Get Bucked by the Mechanical Bull: Holding onto Adversarial Ethics While Riding Innovations.” The panel will include a group of legal experts who will discuss appellate decisions, i.e., what constitutes injury-in-fact, and how this creates ethical (assessing class conflicts), strategic (crafting class definitions), and policy (balancing rigor with efficiency) concerns.
Program topics include: “Public Nuisance—New Mass-Litigation Sheriff in Town?” “Class-Action Round Up—The Year in Jurisprudence,” Class-Action Conniption! How In-House Counsel Lasso Class Actions on “Class Actions Live!” “The Coordination Rodeo: Options for Lassoing Parallel Proceedings” among others.
Click here to view the full program agenda.
About David Rudolph
A partner in our San Francisco office, David Rudolph is a member of the firm’s Cybersecurity and Data Privacy and Antitrust and Intellectual Property practice groups. He has extensive experience litigating core technical issues in privacy cases, including In re Anthem, Inc. Data Breach Litigation, MDL No. 2617 (N.D. Cal.), arising from a data breach that affected nearly 80 million of Anthem’s members, and Campbell v. Facebook, Inc., No. 5:13-cv- 5996 (N.D. Cal.), in which Facebook users asserted that Facebook violated their privacy rights by scanning their private email messages.
David has represented end-payor classes in pharmaceutical antitrust litigation, including in the Cipro drug antitrust cases, the Restasis antitrust litigation, and the Generic Pharmaceuticals Price-Fixing cases. In 2017, David was awarded “Outstanding Private Practice Antitrust Achievement” by the American Antitrust Institute for his work on the Cipro case. He also represents plaintiffs in In re Domestic Airline Travel Antitrust Litigation (D.D.C.), a class action lawsuit alleging a conspiracy by United, American, Delta, and Southwest to artificially inflate domestic airline ticket prices by limiting capacity.